|
US6696475B2
(en)
|
1997-04-22 |
2004-02-24 |
Neurosearch A/S |
Substituted phenyl derivatives, their preparation and use
|
|
ATE291011T1
(de)
*
|
1997-12-22 |
2005-04-15 |
Bayer Pharmaceuticals Corp |
Hemmung der raf-kinase unter verwendung von symmetrisch und unsymmetrisch substituierten harnstoffen
|
|
EP1514867A3
(en)
*
|
1998-10-22 |
2005-03-23 |
NeuroSearch A/S |
Substituted phenyl derivatives, their preparation and use
|
|
US20050080112A1
(en)
*
|
2001-06-22 |
2005-04-14 |
Madsen Lars Siim |
Compounds for use in disorders associated with mast cell or basophil acitvity
|
|
US7087631B2
(en)
*
|
2002-07-18 |
2006-08-08 |
Inotek Pharmaceuticals Corporation |
Aryltetrazole compounds, and compositions thereof
|
|
US7078423B2
(en)
*
|
2002-07-18 |
2006-07-18 |
Inotek Pharmaceuticals Corporation |
5-Aryltetrazole compounds, compositions thereof, and uses therefor
|
|
CA2493253A1
(en)
*
|
2002-08-01 |
2004-02-12 |
Neurosearch A/S |
Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy
|
|
CA2495284A1
(en)
*
|
2002-09-05 |
2004-03-18 |
Neurosearch A/S |
Diarylurea derivatives and their use as chloride channel blockers
|
|
AU2003258491A1
(en)
*
|
2002-09-05 |
2004-03-29 |
Neurosearch A/S |
Amide derivatives and their use as chloride channel blockers
|
|
WO2004033632A2
(en)
*
|
2002-10-04 |
2004-04-22 |
Bristol-Myers Squibb Company |
Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace)
|
|
US7521480B2
(en)
|
2002-11-21 |
2009-04-21 |
Neurosearch |
Aryl ureido benzoic acid derivatives and their use
|
|
WO2004058722A1
(en)
*
|
2002-12-24 |
2004-07-15 |
Arena Pharmaceuticals, Inc. |
Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a
|
|
CN1805942B
(zh)
*
|
2003-06-17 |
2010-06-02 |
神经研究公司 |
二苯基脲衍生物及其作为氯离子通道阻断剂的用途
|
|
NZ544331A
(en)
|
2003-07-22 |
2010-03-26 |
Arena Pharm Inc |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
|
|
US7202363B2
(en)
|
2003-07-24 |
2007-04-10 |
Abbott Laboratories |
Thienopyridine and furopyridine kinase inhibitors
|
|
CN1845726A
(zh)
*
|
2003-09-04 |
2006-10-11 |
波塞东医药公司 |
用于治疗心脏心律失常的erg通道开放剂
|
|
WO2005023238A1
(en)
*
|
2003-09-04 |
2005-03-17 |
Poseidon Pharmaceuticals A/S |
Erg channel openers for the treatment of hyperexcitability-related neuronal diseases
|
|
EP1678123A1
(en)
*
|
2003-10-15 |
2006-07-12 |
Bayer HealthCare AG |
Tetrahydro-naphthalene and urea derivatives
|
|
WO2005087236A1
(en)
*
|
2004-03-11 |
2005-09-22 |
Glaxo Group Limited |
Novel m3 muscarinic acetylcholine receptor antagonists
|
|
CN1926114B
(zh)
*
|
2004-03-23 |
2011-08-24 |
艾尼纳制药公司 |
用于制备经取代n-芳基-n′-′3-(1h-吡唑-5-基)苯基脲及其中间体的方法
|
|
PE20061130A1
(es)
*
|
2004-11-19 |
2007-01-05 |
Arena Pharm Inc |
Derivados de 3-fenil-pirazol como moduladores del receptor de serotonina 5-ht2a
|
|
CA2592118C
(en)
*
|
2004-12-23 |
2015-11-17 |
Deciphera Pharmaceuticals, Llc |
Urea derivatives as enzyme modulators
|
|
EP2027119A2
(en)
*
|
2006-05-18 |
2009-02-25 |
Arena Pharmaceuticals, Inc. |
Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
US8148417B2
(en)
*
|
2006-05-18 |
2012-04-03 |
Arena Pharmaceuticals, Inc. |
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
|
|
NZ571829A
(en)
|
2006-05-18 |
2011-10-28 |
Arena Pharm Inc |
Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT2A serotonin receptor
|
|
TWI415845B
(zh)
|
2006-10-03 |
2013-11-21 |
Arena Pharm Inc |
用於治療與５-ｈｔ2ａ血清素受體相關聯病症之作為５-ｈｔ2ａ血清素受體之調節劑的吡唑衍生物
|
|
US7790756B2
(en)
*
|
2006-10-11 |
2010-09-07 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
|
|
EP2152677A1
(en)
|
2007-05-03 |
2010-02-17 |
NeuroSearch A/S |
Acetamide derivatives as potassium channel modulators
|
|
ES2421237T7
(es)
|
2007-08-15 |
2013-09-30 |
Arena Pharmaceuticals, Inc. |
Derivados de imidazo[1,2-a]piridin como moduladores del receptor serotoninérgico 5ht2a en el tratamiento de trastornos relacionados con el mismo
|
|
WO2009123714A2
(en)
*
|
2008-04-02 |
2009-10-08 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
|
|
US9126946B2
(en)
|
2008-10-28 |
2015-09-08 |
Arena Pharmaceuticals, Inc. |
Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
|
|
TR201805216T4
(en)
|
2008-10-28 |
2018-06-21 |
Arena Pharm Inc |
COMPOSITIONS OF A USEFUL 5-HT2A SEROTONINE RECEPTOR MODULATOR FOR THE TREATMENT OF RELATED DISORDERS
|
|
KR101639642B1
(ko)
|
2008-12-05 |
2016-07-14 |
애브비 바하마스 리미티드 |
암 치료에 사용하기 위한 키나제 억제제로서의 티에노［3,2-ｃ］피리딘 유도체
|
|
US8980891B2
(en)
|
2009-12-18 |
2015-03-17 |
Arena Pharmaceuticals, Inc. |
Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
|
|
US8436179B2
(en)
|
2011-07-20 |
2013-05-07 |
Abbvie Inc. |
Kinase inhibitor with improved solubility profile
|
|
CN103709185A
(zh)
*
|
2013-12-30 |
2014-04-09 |
大连联化医药技术有限公司 |
一种4-(n-甲基甲酰氨)苯基硼酸的制备方法
|
|
JP2018516992A
(ja)
|
2015-06-12 |
2018-06-28 |
アクソファント サイエンシーズ ゲーエムベーハーＡｘｏｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ |
レム睡眠行動障害の予防および処置のために有用なジアリールおよびアリールヘテロアリール尿素誘導体
|
|
CN108472285A
(zh)
|
2015-07-15 |
2018-08-31 |
阿速万科学有限责任公司 |
用于预防和治疗与神经退行性疾病相关联的幻觉的二芳基和芳基杂芳基脲衍生物
|
|
ES2770374T3
(es)
|
2016-05-17 |
2020-07-01 |
Scandion Oncology As |
Tratamiento combinado de cáncer
|
|
AU2018300150A1
(en)
|
2017-07-11 |
2020-01-30 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
WO2020146612A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Esters and carbamates as modulators of sodium channels
|
|
WO2020146682A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
CN117229258B
(zh)
*
|
2022-06-07 |
2024-07-19 |
杭州壹瑞医药科技有限公司 |
N-四唑基芳基脲类衍生物及其制备方法和应用
|